We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
+31.36%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$25.4M
Cap. Flow
-$2.31M
Cap. Flow %
-1.83%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
2
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$10M
2
QTRX icon
Quanterix
QTRX
+$3.26M
3
PSNL icon
Personalis
PSNL
+$2.33M

Top Sells

Rank Stock Value
1
GH icon
Guardant Health
GH
+$11.4M
2
NTRA icon
Natera
NTRA
+$6.55M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
1
Natera
NTRA
$46.9B
$28.1M 22.26%
166,494
-42,000
-20% -$6.55M
ADPT icon
2
Adaptive Biotechnologies
ADPT
$4.07B
$25M 19.78%
2,145,145
– –
GH icon
3
Guardant Health
GH
$21.9B
$22.8M 18.09%
439,047
-255,000
-37% -$11.4M
CDNA icon
4
CareDx
CDNA
$2.41B
$14.1M 11.2%
724,014
– –
TXG icon
5
10x Genomics
TXG
$8.1B
$12.7M 10.09%
+1,100,720
New +$10M
PSNL icon
6
Personalis
PSNL
$1.69B
$11M 8.7%
1,676,300
+500,900
+43% +$2.33M
QTRX icon
7
Quanterix
QTRX
$140M
$6.37M 5.04%
957,747
+585,572
+157% +$3.26M
AKYA
8
DELISTED
Akoya BioSciences
AKYA
$6.11M 4.83%
4,697,785
– –

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Blue Water Life Science Advisors held 8 positions worth $126M, up 25% from $101M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blue Water Life Science Advisors's Q2 2025 filing shows 1 new, 2 increased and 2 reduced positions. Its largest new stake was 10x Genomics: 1,100,720 shares worth $12.7M. The largest sale was Guardant Health, an estimated $11.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Blue Water Life Science Advisors's largest Q2 2025 buy was 10x Genomics: 1,100,720 shares worth $12.7M.
  • Blue Water Life Science Advisors added most to Quanterix in Q2 2025, an estimated $3.26M increase.
  • Blue Water Life Science Advisors's biggest Q2 2025 reduction was Guardant Health, cutting an estimated $11.4M.
  • Blue Water Life Science Advisors's ten largest holdings make up 100% of its $126M portfolio in Q2 2025.
  • Blue Water Life Science Advisors opened 1 new position and closed 0 in Q2 2025.
  • Blue Water Life Science Advisors's portfolio value rose 25% quarter-over-quarter to $126M.

Based on Blue Water Life Science Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.